Document is current

Any future updates will be listed below

Vielversprechende Phase-II-Daten zu einem neuen KRAS-Inhibitor

Crossref DOI link: https://doi.org/10.1007/s15033-022-3430-z

Published Online: 2022-12-15

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark